Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia
β Scribed by R. Stohler; U. Keller; W. F. Riesen
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 577 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effects of the HMG CoA reductase inhibitors lovastatin and pravastatin on serum lipids, lipoproteins and apolipoproteins have been studied in 35 patients with primary hypercholesterolaemia. LDL cholesterol was lowered to the same extent by both agents compared on a mg basis of each drug per day.
The effects of two moderate doses of long-chain n-3 fatty acids (3.0 and 4.5 g EPA+ DHA per day for 4 weeks each) on serum lipids and lipoproteins of patients with familial combined hyperlipidemia (FCH) were studied in a doubleblind, placebo-controlled clinical trial. In nine patients with FCH n-3 f